Quick Answer
Oncology Institute, Inc. reported Stockholders Equity of -$15.72 million for fiscal year 2025.
Oncology Institute, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$15.72M | -538.0% |
| 2024 | $3.59M | -93.7% |
| 2023 | $57.02M | -53.7% |
| 2022 | $123.17M | +18.3% |
| 2021 | $104.16M | +270.7% |
| 2020 | $28.10M | -33.4% |
| 2019 | $42.22M | — |
| 2019 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$12.27M | -179.3% | -36.6% |
| June 30, 2025 | -$8.98M | -130.8% | -277.3% |
| March 31, 2025 | $5.07M | -87.7% | +41.2% |
| December 31, 2024 | $3.59M | -93.7% | -76.8% |
| September 30, 2024 | $15.48M | -78.5% | -47.0% |
| June 30, 2024 | $29.21M | -65.5% | -29.3% |
| March 31, 2024 | $41.30M | -58.0% | -27.6% |
| December 31, 2023 | $57.02M | -53.7% | -20.6% |
- Oncology Institute, Inc. showed a decrease of -538.0% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Oncology Institute, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: